Sandbox Reserved 1063
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
== Introduction == | == Introduction == | ||
''<scene name='69/694230/Fadd13_subunits/4'>FadD13</scene>'' ''Mycobacterium Tuberculosis'' is an ACSVL (Acyl-CoA synthetases very long) peripheral membrane protein<ref>PMID: 17762044</ref>. ACS proteins activate [http://en.wikipedia.org/wiki/Lipid lipids] and [http://en.wikipedia.org/wiki/Fatty_acid fatty acids] before going into [http://en.wikipedia.org/wiki/Metabolic_pathway metabolic pathways]. FadD13 is soluble unlike other ACSVL proteins. FadD13 contains a hydrophobic tunnel for fatty acids to bind to, as well as an arginine rich lid loop that binds to the cell membrane. The binding of ATP causes structural changes promoting the binding of the hydrophobic substrates. Formation of an acyl-adenylate intermediate induces a 140 degree rotation of the small domain and binding of [http://en.wikipedia.org/wiki/Coenzyme_A CoA] for production of the final product, a fatty acyl-CoA thioester<ref>PMID: 19345228</ref>. Shown below is the general mechanism for ACS proteins. | ''<scene name='69/694230/Fadd13_subunits/4'>FadD13</scene>'' ''Mycobacterium Tuberculosis'' is an ACSVL (Acyl-CoA synthetases very long) peripheral membrane protein<ref>PMID: 17762044</ref>. ACS proteins activate [http://en.wikipedia.org/wiki/Lipid lipids] and [http://en.wikipedia.org/wiki/Fatty_acid fatty acids] before going into [http://en.wikipedia.org/wiki/Metabolic_pathway metabolic pathways]. FadD13 is soluble unlike other ACSVL proteins. FadD13 contains a hydrophobic tunnel for fatty acids to bind to, as well as an arginine rich lid loop that binds to the cell membrane. The binding of ATP causes structural changes promoting the binding of the hydrophobic substrates. Formation of an acyl-adenylate intermediate induces a 140 degree rotation of the small domain and binding of [http://en.wikipedia.org/wiki/Coenzyme_A CoA] for production of the final product, a fatty acyl-CoA thioester<ref>PMID: 19345228</ref>. Shown below is the general mechanism for ACS proteins. | ||
- | [[Image:FadD13 steps.png|390 px|thumb|left| | + | [[Image:FadD13 steps.png|390 px|thumb|left|Figure 1 shows the general outline of the binding of ATP and acyl substrates to an ACSVL enzyme. This is the accepted mechanism for these types of proteins.]] |
- | + | ||
== Background == | == Background == | ||
Line 16: | Line 15: | ||
The FadD13 enzyme functions to activate lipids. Once the lipids are activated, they can continue on into metabolic pathways. This is done by ATP/AMP binding to the <scene name='69/694230/Atp_and_amp_binding_region/14'>ATP/AMP binding region</scene>. Once ATP/AMP is bound, the long lipid chain up to 26 carbons may bind in the hydrophobic portion of the enzyme. Upon binding of the substrate, the C terminal swings up to close off the tunnel. From there CoA can bind to produce the final product, an acyl-CoA Thioester. The lipid can now move transversely throughout the membrane and throughout the rest of the cell. Below is the proposed mechanism for ACSVL proteins. | The FadD13 enzyme functions to activate lipids. Once the lipids are activated, they can continue on into metabolic pathways. This is done by ATP/AMP binding to the <scene name='69/694230/Atp_and_amp_binding_region/14'>ATP/AMP binding region</scene>. Once ATP/AMP is bound, the long lipid chain up to 26 carbons may bind in the hydrophobic portion of the enzyme. Upon binding of the substrate, the C terminal swings up to close off the tunnel. From there CoA can bind to produce the final product, an acyl-CoA Thioester. The lipid can now move transversely throughout the membrane and throughout the rest of the cell. Below is the proposed mechanism for ACSVL proteins. | ||
- | [[Image:Proposed Mechanism.png|390 px|thumb|left| | + | [[Image:Proposed Mechanism.png|390 px|thumb|left|Figure 2 shows the proposed mechanism for an ACSVL protein bound to the membrane<ref>PMID: 22560731</ref>]] |
- | + | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
{{reflist}} | {{reflist}} |
Revision as of 02:05, 21 April 2015
FadD13
|
References
- ↑ Watkins PA, Maiguel D, Jia Z, Pevsner J. Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J Lipid Res. 2007 Dec;48(12):2736-50. Epub 2007 Aug 30. PMID:17762044 doi:http://dx.doi.org/M700378-JLR200
- ↑ Kochan G, Pilka ES, von Delft F, Oppermann U, Yue WW. Structural snapshots for the conformation-dependent catalysis by human medium-chain acyl-coenzyme A synthetase ACSM2A. J Mol Biol. 2009 May 22;388(5):997-1008. Epub 2009 Apr 1. PMID:19345228 doi:10.1016/j.jmb.2009.03.064
- ↑ Khare G, Gupta V, Gupta RK, Gupta R, Bhat R, Tyagi AK. Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis. PLoS One. 2009 Dec 21;4(12):e8387. doi: 10.1371/journal.pone.0008387. PMID:20027301 doi:10.1371/journal.pone.0008387
- ↑ Khare G, Gupta V, Gupta RK, Gupta R, Bhat R, Tyagi AK. Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis. PLoS One. 2009 Dec 21;4(12):e8387. doi: 10.1371/journal.pone.0008387. PMID:20027301 doi:10.1371/journal.pone.0008387
- ↑ Andersson CS, Lundgren CA, Magnusdottir A, Ge C, Wieslander A, Molina DM, Hogbom M. The Mycobacterium tuberculosis Very-Long-Chain Fatty Acyl-CoA Synthetase: Structural Basis for Housing Lipid Substrates Longer than the Enzyme. Structure. 2012 May 2. PMID:22560731 doi:10.1016/j.str.2012.03.012
- ↑ Andersson CS, Lundgren CA, Magnusdottir A, Ge C, Wieslander A, Molina DM, Hogbom M. The Mycobacterium tuberculosis Very-Long-Chain Fatty Acyl-CoA Synthetase: Structural Basis for Housing Lipid Substrates Longer than the Enzyme. Structure. 2012 May 2. PMID:22560731 doi:10.1016/j.str.2012.03.012